Detalles de la búsqueda
1.
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study.
Acta Oncol
; 63: 213-219, 2024 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38647024
2.
Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Future Oncol
; 18(23): 2593-2604, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35722877
3.
Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs.
Tumori
; : 3008916241246659, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38623748
4.
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.
Tumori
; 110(3): 168-173, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38372045
5.
The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project.
Cancer Med
; 13(9): e7159, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38741546
6.
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Clin Lung Cancer
; 25(2): 190-195, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38262770
7.
Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Clin Lung Cancer
; 24(7): 631-640.e2, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37775370
8.
High bone tumor burden to identify advanced non-small cell lung cancer patients with survival benefit upon bone targeted agents and immune checkpoint inhibitors.
Lung Cancer
; 186: 107417, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37918061
9.
STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines.
J Thorac Oncol
; 18(8): 1070-1081, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37094664
10.
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy.
Clin Lung Cancer
; 24(4): 381-387, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36959048
11.
PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis.
J Immunother Cancer
; 11(6)2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37286305
12.
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin.
Front Oncol
; 12: 925551, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36059635
13.
Efficacy of mRNA anti-SARS-CoV-2 vaccination and dynamics of humoral immune response in patients with solid tumors: results from the institutional registry of an Italian tertiary cancer center.
Ther Adv Med Oncol
; 14: 17588359221108687, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35923922
14.
Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.
Front Oncol
; 12: 1078822, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36755856
15.
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy.
Target Oncol
; 16(4): 529-536, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34076798
16.
Antitumor activity and efficacy of shorter versus longer duration of anthracycline-taxane neoadjuvant chemotherapy in stage II-III HER2-negative breast cancer: a 10-year, retrospective analysis.
Ther Adv Med Oncol
; 12: 1758835920970081, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33335565
Resultados
1 -
16
de 16
1
Próxima >
>>